Literature DB >> 31666399

Multiple roles for HIV broadly neutralizing antibodies.

Barton F Haynes1, Dennis R Burton2,3, John R Mascola4.   

Abstract

Potent broadly neutralizing antibodies may be used to treat or prevent HIV and to help guide HIV vaccine design.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31666399      PMCID： PMC7171597          DOI： 10.1126/scitranslmed.aaz2686

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  10 in total

Review 1.  What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.

Authors:  Dennis R Burton
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

Review 2.  Advances in structure-based vaccine design.

Authors:  Daniel W Kulp; William R Schief
Journal:  Curr Opin Virol       Date:  2013-06-25       Impact factor: 7.090

Review 3.  Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.

Authors:  Yoshiaki Nishimura; Malcolm A Martin
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

Review 4.  HIV-1 neutralizing antibodies: understanding nature's pathways.

Authors:  John R Mascola; Barton F Haynes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 5.  HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

6.  B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors:  Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

Review 7.  Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.

Authors:  Marina Caskey; Florian Klein; Michel C Nussenzweig
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

Review 8.  HIV-Host Interactions: Implications for Vaccine Design.

Authors:  Barton F Haynes; George M Shaw; Bette Korber; Garnett Kelsoe; Joseph Sodroski; Beatrice H Hahn; Persephone Borrow; Andrew J McMichael
Journal:  Cell Host Microbe       Date:  2016-02-25       Impact factor: 21.023

Review 9.  Native-like Env trimers as a platform for HIV-1 vaccine design.

Authors:  Rogier W Sanders; John P Moore
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 10.  Recent progress in broadly neutralizing antibodies to HIV.

Authors:  Devin Sok; Dennis R Burton
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 31.250
  10 in total
  53 in total

1.  Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.

Authors:  Bharat Madan; Baoshan Zhang; Kai Xu; Cara W Chao; Sijy O'Dell; Jacy R Wolfe; Gwo-Yu Chuang; Ahmed S Fahad; Hui Geng; Rui Kong; Mark K Louder; Thuy Duong Nguyen; Reda Rawi; Arne Schön; Zizhang Sheng; Rajani Nimrania; Yiran Wang; Tongqing Zhou; Bob C Lin; Nicole A Doria-Rose; Lawrence Shapiro; Peter D Kwong; Brandon J DeKosky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

2.  A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.

Authors:  Peng Zhang; Elisabeth Narayanan; Qingbo Liu; Yaroslav Tsybovsky; Kristin Boswell; Shilei Ding; Zonghui Hu; Dean Follmann; Yin Lin; Huiyi Miao; Hana Schmeisser; Denise Rogers; Samantha Falcone; Sayda M Elbashir; Vladimir Presnyak; Kapil Bahl; Madhu Prabhakaran; Xuejun Chen; Edward K Sarfo; David R Ambrozak; Rajeev Gautam; Malcom A Martin; Joanna Swerczek; Richard Herbert; Deborah Weiss; Johnathan Misamore; Giuseppe Ciaramella; Sunny Himansu; Guillaume Stewart-Jones; Adrian McDermott; Richard A Koup; John R Mascola; Andrés Finzi; Andrea Carfi; Anthony S Fauci; Paolo Lusso
Journal:  Nat Med       Date:  2021-12-09       Impact factor: 53.440

Review 3.  Curing HIV: Seeking to Target and Clear Persistent Infection.

Authors:  David M Margolis; Nancie M Archin; Myron S Cohen; Joseph J Eron; Guido Ferrari; J Victor Garcia; Cynthia L Gay; Nilu Goonetilleke; Sarah B Joseph; Ronald Swanstrom; Anne-Marie W Turner; Angela Wahl
Journal:  Cell       Date:  2020-03-26       Impact factor: 41.582

4.  HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities.

Authors:  Hongbing Yang; Margarida Rei; Simon Brackenridge; Elena Brenna; Hong Sun; Shaheed Abdulhaqq; Michael K P Liu; Weiwei Ma; Prathiba Kurupati; Xiaoning Xu; Vincenzo Cerundolo; Edward Jenkins; Simon J Davis; Jonah B Sacha; Klaus Früh; Louis J Picker; Persephone Borrow; Geraldine M Gillespie; Andrew J McMichael
Journal:  Sci Immunol       Date:  2021-03-25

5.  Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.

Authors:  Daniel P Leaman; Armando Stano; Yajing Chen; Lei Zhang; Michael B Zwick
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

6.  Rapid, user-friendly, and inexpensive detection of azidothymidine.

Authors:  Ying Luo; Tianwei Jia; Jieqiong Fang; Dandan Liu; Varma Saikam; Xiaolin Sheng; Suri S Iyer
Journal:  Anal Bioanal Chem       Date:  2021-01-23       Impact factor: 4.142

Review 7.  50 Years of Structural Immunology.

Authors:  Ian A Wilson; Robyn L Stanfield
Journal:  J Biol Chem       Date:  2021-05-03       Impact factor: 5.157

8.  New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.

Authors:  Hui Li; Shuyi Wang; Fang-Hua Lee; Ryan S Roark; Alex I Murphy; Jessica Smith; Chengyan Zhao; Juliette Rando; Neha Chohan; Yu Ding; Eunlim Kim; Emily Lindemuth; Katharine J Bar; Ivona Pandrea; Cristian Apetrei; Brandon F Keele; Jeffrey D Lifson; Mark G Lewis; Thomas N Denny; Barton F Haynes; Beatrice H Hahn; George M Shaw
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

Review 9.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

10.  Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.

Authors:  Ryan S Roark; Hui Li; Wilton B Williams; Hema Chug; Rosemarie D Mason; Jason Gorman; Shuyi Wang; Fang-Hua Lee; Juliette Rando; Mattia Bonsignori; Kwan-Ki Hwang; Kevin O Saunders; Kevin Wiehe; M Anthony Moody; Peter T Hraber; Kshitij Wagh; Elena E Giorgi; Ronnie M Russell; Frederic Bibollet-Ruche; Weimin Liu; Jesse Connell; Andrew G Smith; Julia DeVoto; Alexander I Murphy; Jessica Smith; Wenge Ding; Chengyan Zhao; Neha Chohan; Maho Okumura; Christina Rosario; Yu Ding; Emily Lindemuth; Anya M Bauer; Katharine J Bar; David Ambrozak; Cara W Chao; Gwo-Yu Chuang; Hui Geng; Bob C Lin; Mark K Louder; Richard Nguyen; Baoshan Zhang; Mark G Lewis; Donald D Raymond; Nicole A Doria-Rose; Chaim A Schramm; Daniel C Douek; Mario Roederer; Thomas B Kepler; Garnett Kelsoe; John R Mascola; Peter D Kwong; Bette T Korber; Stephen C Harrison; Barton F Haynes; Beatrice H Hahn; George M Shaw
Journal:  Science       Date:  2020-11-19       Impact factor: 47.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.